SA
Go ProLog In
KOD
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
18 analysts·Moderate coverage
67
Score
13 Buy (72%)4 Hold (22%)1 Sell (6%)
Rating Breakdown
Strong Buy
00%
Buy
1372%
Hold
422%
Sell
16%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$56.00
+53.2%
Consensus
$59.50
+62.8%
Bull
$80.00
+118.9%
12-Month Target Range18 analysts
$56.00$59.50$80.00
Current $36.55Consensus
Current Price
$36.55
Upside to Consensus
$22.95

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+305.62%
EPS—
FY2028
Rev+414.64%
EPS—
FY2029
Rev+110.72%
EPS—

Earnings Surprises

Recent Analyst Actions

May 11, 2026Chardan Capital
Kodiak Sciences upgraded to Buy from Neutral at Chardan
Target:$61.00
+47.4%from $41.38
Mar 27, 2026UBS
Kodiak Sciences price target raised to $80 from $50 at UBS
Target:$80.00
+116.2%from $37.00
Mar 27, 2026H.C. Wainwright
Kodiak Sciences price target raised to $58 from $38 at H.C. Wainwright
Target:$58.00
+56.8%from $37.00
Mar 26, 2026Jefferies
Kodiak Sciences price target raised to $56 from $39 at Jefferies
Target:$56.00
+40.8%from $39.76
Jan 22, 2026H.C. Wainwright
Kodiak Sciences price target raised to $38 from $26 at H.C. Wainwright
Target:$38.00
+42.3%from $26.71
Jan 7, 2026UBS
UBS Starts Kodiak Sciences Inc. (KOD) at Buy
Target:$50.00
+99.6%from $25.05
Sep 25, 2025Barclays
Kodiak Sciences upgraded to Equal Weight from Underweight at Barclays
Target:$17.00
+9.7%from $15.49
Dec 9, 2024Jefferies
Jefferies Upgrades Kodiak Sciences Inc. (KOD) to Buy
Target:$20.00
+74.2%from $11.48
Sep 24, 2024Goldman Sachs
Goldman Sachs Reiterates Sell Rating on Kodiak Sciences Inc. (KOD)
Target:$2.00
-17.8%from $2.43
Nov 14, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Kodiak Sciences, Lowers Price Target to $9
Target:$9.00
+18.6%from $7.59
Nov 10, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on Kodiak Sciences, Lowers Price Target to $8
Target:$8.00
+10.8%from $7.22
Aug 15, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Kodiak Sciences, Raises Price Target to $12
Target:$12.00
+2.3%from $11.73
Aug 10, 2022Chardan Capital
Chardan Capital Maintains Buy on Kodiak Sciences, Lowers Price Target to $18
Target:$18.00
+52.0%from $11.84
Aug 9, 2022Truist Financial
Truist Securities Maintains Buy on Kodiak Sciences, Raises Price Target to $15
Target:$15.00
+34.8%from $11.13
Aug 9, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on Kodiak Sciences, Raises Price Target to $9
Target:$9.00
-22.1%from $11.55
May 24, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on Kodiak Sciences, Lowers Price Target to $5
Target:$5.00
-23.7%from $6.55
May 11, 2022Goldman Sachs
Goldman Sachs Maintains Neutral on Kodiak Sciences, Lowers Price Target to $7
Target:$7.00
+34.6%from $5.20
Feb 11, 2022Goldman Sachs
Kodiak Sciences (KOD) initiated with a Buy at Goldman Sachs
Target:$70.00
+23.3%from $56.79
Nov 12, 2021BMO Capital
Kodiak Sciences price target raised to $114 from $104 at BMO Capital
Target:$114.00
+1.5%from $112.33

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance